UBS Group’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

UBS Group’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$19.5K	–	11447
2022 Q4	$19.5K	Buy	+1,000	New	+$20.1K	﹤0.01%	7674
2022 Q1	–	Sell	-6	Closed	–	–	11333
2021 Q4	$0	Buy	+6	New	+$289	﹤0.01%	11076
2021 Q2	–	Sell	-387	Closed	-$18K	–	10082
2021 Q1	$18K	Buy	387 +287	+287%	+$13.8K	﹤0.01%	7490
2020 Q4	$5K	Buy	+100	New	+$4.77K	﹤0.01%	7864
2020 Q2	–	Sell	-197	Closed	-$8K	–	8520
2020 Q1	$8K	Buy	+197	New	+$9.43K	﹤0.01%	7105

UBS Group's ELAT Position: Q1 2023 in Review

UBS Group sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 1,000 shares — an estimated $19.5K sold.

UBS Group first reported a position in ELAT in Q1 2020 and held it in 5 quarters. The position peaked at $19.5K in Q4 2022. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

UBS Group reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
UBS Group sold 1,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $19.5K.
UBS Group first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 5 quarters.
UBS Group's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $19.5K in Q4 2022.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.